InvestorsHub Logo
Followers 2
Posts 319
Boards Moderated 0
Alias Born 08/29/2018

Re: None

Monday, 04/19/2021 11:30:58 AM

Monday, April 19, 2021 11:30:58 AM

Post# of 27409
SP Only down becuz of the "conditional" IDE. I have a few shares left and I for one am not selling here. I think today's news is wonderful and once the conditional nature of the approval to begin the trial is relinquished I see us easily going back up over $9. It is a little unusual to have a conditional tag on the approval to begin a trial however given the important nature of this most critical trial I see it only as a positive. I wish people here would remain patient as the beads could very well be one of the 21st centuries most medically altering and beneficial finds. Speculating of course as others used to when the daily idea of $60 and $80 per common share were announced on a regular basis. I'm not calling for that however given my purchase price anything around $10 makes me a happy camper! Better yet, it looks as though filtration is becoming a viable covid option as well!!

Dr. Kellum co-author on COVID-19 and PMX research
Endotoxin Adsorbent Therapy in Severe COVID-19 Pneumonia
"Conclusions: We demonstrated the clinical improvement of severe COVID-19 patients with elevated EAA level upon receiving EA therapy."

Two interesting notes- the testing was done before Dr. Kellum joined Spectral (no affiliation noted) and that the testing was was guided and monitored using our EAA


GLTA!!!!!!!!!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News